pH-Responsive Diblock Copolymer for Tumor-Specific Fluorescence Imaging

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current intra-operative imaging technologies for tumors face challenges in real-time imaging during surgery due to hardware limitations and lack of tumor specificity, leading to inaccurate boundary determination and increased surgical risks, with existing imaging agents having issues with false positives, false negatives, and prolonged clearance times.

Innovation Solution

Development of a functionalized diblock copolymer that is pH-responsive and degradable, allowing for targeted accumulation at tumor sites through protonatable groups, fluorescent molecular groups, and delivery molecular groups, enhancing tumor specificity and rapid clearance.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional imaging agents are used, then imaging can be performed, but tumor specificity is poor leading to false positives and false negatives

Engineering Contradiction:
Improvetumor imaging accuracyVSAvoidtumor specificity
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The diblock copolymer imaging agent exhibits different properties in different environments: in the acidic tumor microenvironment (pH 6.5-7.0), the protonatable groups become protonated, changing the polymer's charge state and triggering fluorescence emission. This local environmental response enables the agent to specifically accumulate at tumor sites and provide accurate imaging, resolving the contradiction between imaging capability and tumor specificity.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The imaging agent's fluorescence emission is controlled by pH parameter changes. The protonatable groups undergo protonation/deprotonation transitions in response to pH changes between normal tissue (pH 7.4) and tumor microenvironment (pH 6.5-7.0). This parameter-driven transition allows the agent to remain silent in normal tissue and activate specifically at tumor sites, achieving high tumor-to-normal tissue ratios and eliminating false positives.

Inventive Principle:
Principle #35Parameter changes

2Measurement precision

If imaging agents with prolonged clearance times are used, then imaging can be performed, but surgical time is increased and patient risk increases

Engineering Contradiction:
Improveimaging capabilityVSAvoidclearance time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The diblock copolymer imaging agent exhibits dynamic clearance behavior: it accumulates at tumor sites through passive targeting and protonation-driven accumulation, then rapidly clears from normal tissue and is excreted through urine. This dynamic profile allows the agent to provide imaging information quickly without prolonged retention, reducing surgical time and patient risk while maintaining imaging precision.

Inventive Principle:
Principle #15Dynamics

3Reliability

If protonatable groups are introduced to enhance tumor accumulation, then tumor specificity improves, but agent stability in blood may be affected

Engineering Contradiction:
Improvetumor accumulationVSAvoidblood stability
Core Design Contradiction:
ReliabilityVSStability of the object's composition

Solution Approach 1:

The protonatable groups undergo pH-dependent protonation changes: in the neutral blood environment (pH 7.4), they remain deprotonated and stable, maintaining blood compatibility. In the acidic tumor microenvironment (pH 6.5-7.0), they become protonated, triggering accumulation and fluorescence emission. This parameter-driven transition allows the agent to maintain stability in blood while achieving enhanced tumor accumulation, resolving the contradiction between stability and tumor targeting.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The diblock copolymer provides enhanced tumor imaging with high tumor-to-normal tissue ratios, reducing surgical time and recurrence rates by ensuring accurate tumor boundary identification and rapid agent clearance.

Implementation Method 1

Because the target site has a special pH environment (for example, an acidic environment), the protonatable group can be protonated in this pH environment, and the charge repulsion generated by its protonation and the increase in polymer solubility drive the disintegration of polymer particles

Methodology Applied
Scientific EffectProtonation: Ionisation

Implementation Method 2

C2 is selected from fluorescent molecular groups

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Data Source

PatentUS20250345457A1Functionalized diblock copolymer and its preparation method and application
Publication Date: 2025.11.13 INNOVATINGBIO (SHANGHAI) CO LTD
  • US20250345457A1 patent drawing
  • US20250345457A1 patent drawing
  • US20250345457A1 patent drawing

AI summary

A functionalized diblock copolymer. The chemical structure of the functionalized diblock copolymer is shown in Formula II. The functionalized diblock copolymers or polymer particles can be widely used in tumor imaging, tumor treatment and other fields. It not only has good safety, realizes faster and adjustable (by changing the structure and number of functional groups) degradation and removal of polymers under acidic conditions, but also has excellent specificity and high-quality imaging effects at the target site, with high signal-to-noise ratio, clear boundaries, and long half-life. It solves the problem of fluorescence imaging technology in real-time intra-operative navigation, which has a good industrialization prospect.